Document is current

Article History

Received: 24 June 2024

Accepted: 18 March 2025

First Online: 5 April 2025

Declarations

:

: This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving research study participants were approved by the Institutional Review Boards of the Institut de Recherche en Sciences de la Santé (IRSS, Bobo-Dioulasso) and the Hauts-Bassins Health Department, respectively, under the reference numbers N/Ref A11- 2016/CEIRES and N°2016- EE0202/MS/RHBS/DRS. Before enrolling the child in the study, caregivers provided written informed consents for participation of their child in the study and for collection of biological samples. Children who tested positive for malaria using blood smear were treated with a combination of artemether and lumefantrine over 3 days. Children who were diagnosed with intestinal parasites were treated with 400 mg albendazole per day, for 3 days. Children with moderate or mild anemia were referred to an outpatient facility at the health center of Sourkoudougou.

: Not applicable.

: The authors declare no competing interests.